Healthcare. We Care.

Upgrading and expansion of HCG API manufacturing completed

Published 5 Sep 2019

Aspen Oss has completed a major upgrading and expansion project at its hCG manufacturing facility in Boxtel, the Netherlands; an extensive project that was started in 2017.

Through its collection program “Mothers for Mothers”, urine from pregnant Dutch women is collected on a weekly basis. From the urine we extract the API human Chorionic Gonadotrophin (hCG), which is used for fertility treatments.

While hCG was previously produced at two different sites of Aspen Oss, the upgrading of the Boxtel facility has made it possible that the entire production process, from urine to API, can now be performed under one roof, in a dedicated hCG facility.

In order to comply with the highest standards for product safety, Aspen Oss added a virus filtration step in the production process of hCG and successfully validated the new process.

If you want to learn more on how our hCG capabilities can add value to your product, please contact us.

  • All sites
  • Africa Middle East
  • Americas
  • Asia
  • Australasia
  • Europe CIS